PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-4.58%
Revenue decline while CRWD shows 12.54% growth. Joel Greenblatt would examine competitive position erosion.
-7.93%
Cost reduction while CRWD shows 12.42% growth. Joel Greenblatt would examine competitive advantage.
-2.94%
Gross profit decline while CRWD shows 12.59% growth. Joel Greenblatt would examine competitive position.
1.71%
Margin expansion exceeding 1.5x CRWD's 0.04%. David Dodd would verify competitive advantages.
9.52%
R&D growth 1.1-1.25x CRWD's 7.93%. Bill Ackman would demand evidence of superior returns.
6.94%
G&A growth 50-75% of CRWD's 11.35%. Bruce Berkowitz would examine operational efficiency.
4.02%
Marketing expense growth 50-75% of CRWD's 7.21%. Bruce Berkowitz would examine spending effectiveness.
-175.00%
Other expenses reduction while CRWD shows 11.47% growth. Joel Greenblatt would examine efficiency.
6.87%
Similar operating expenses growth to CRWD's 8.14%. Walter Schloss would investigate norms.
-1.65%
Total costs reduction while CRWD shows 9.15% growth. Joel Greenblatt would examine advantage.
-4.19%
Interest expense reduction while CRWD shows 1.70% growth. Joel Greenblatt would examine advantage.
7.92%
D&A growth 50-75% of CRWD's 11.01%. Bruce Berkowitz would examine asset strategy.
-6.24%
EBITDA decline while CRWD shows 29.26% growth. Joel Greenblatt would examine position.
-1.58%
EBITDA margin decline while CRWD shows 37.14% growth. Joel Greenblatt would examine position.
-8.46%
Operating income decline while CRWD shows 15.06% growth. Joel Greenblatt would examine position.
-4.07%
Operating margin decline while CRWD shows 24.53% growth. Joel Greenblatt would examine position.
-164.93%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-10.33%
Pre-tax income decline while CRWD shows 13.38% growth. Joel Greenblatt would examine position.
-6.02%
Pre-tax margin decline while CRWD shows 23.04% growth. Joel Greenblatt would examine position.
-7.68%
Tax expense reduction while CRWD shows 5.55% growth. Joel Greenblatt would examine advantage.
-10.86%
Net income decline while CRWD shows 11.97% growth. Joel Greenblatt would examine position.
-6.58%
Net margin decline while CRWD shows 21.79% growth. Joel Greenblatt would examine position.
-10.80%
EPS decline while CRWD shows 12.00% growth. Joel Greenblatt would examine position.
-10.48%
Diluted EPS decline while CRWD shows 12.00% growth. Joel Greenblatt would examine position.
-0.16%
Share count reduction while CRWD shows 0.85% change. Joel Greenblatt would examine strategy.
-0.28%
Diluted share reduction while CRWD shows 0.85% change. Joel Greenblatt would examine strategy.